Synthesis of a novel PEGylated colon-specific azo-based 4- aminosalicylic acid prodrug

OBJECTIVE(S): 4-aminosalicylic acid (4-ASA) is an isomer of mesalazine that has recently been shown to be effective against inflammatory bowel disease (IBD), and more specifically, ulcerative colitis. However, the majority of orally administered 4-ASA is readily and extensively absorbed from the sto...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeghi, Fatemeh, Eidizade, Atie, Saremnejad, Farinaz, Hadizadeh, Farzin, Khodaverdi, Elham, Akhgari, Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351447/
https://www.ncbi.nlm.nih.gov/pubmed/32695295
http://dx.doi.org/10.22038/ijbms.2020.41152.9736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351447/
https://www.ncbi.nlm.nih.gov/pubmed/32695295
http://dx.doi.org/10.22038/ijbms.2020.41152.9736

Ejemplares similares